Arrowhead Research nets $35.4mm through common and preferred stock offering
- Antisense, Oligonucleotides
- Large Molecule
- Nanotechnology, Chips, etc.
- Site Specific
- Drug Delivery
- Private Investment in Public Equity
- Private Placement
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.